Related Experiment Video
Updated: Jun 20, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Nanotechnology-mediated precision delivery of mRNA
Hongzhang Deng1,2,3, Lin Li4,5,6, Caiyan Zhao4,5,6
1School of Life Science and Technology, Xidian University and Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, Xi'an, China. hzdeng@xidian.edu.cn.
Nature Materials
|June 18, 2026
Summary
Messenger RNA (mRNA) therapies show promise but struggle with targeted delivery due to biological barriers. Nanocarrier strategies are being developed to improve precision delivery for various biomedical applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Biology
Background:
- Messenger RNA (mRNA) therapeutics offer significant potential for disease prevention and treatment.
- Current mRNA therapies face challenges in achieving specific delivery to target organs, tissues, and cells.
- Biological barriers and complex disease physiology hinder the efficacy of mRNA delivery systems.
Purpose of the Study:
- To review heterogeneous barriers affecting mRNA delivery.
- To discuss nanocarrier-mediated strategies for precision mRNA delivery.
- To highlight current limitations and future perspectives in mRNA delivery technology.
Main Methods:
- Literature review of current mRNA delivery approaches.
- Analysis of nanocarrier-based strategies for overcoming biological barriers.
- Discussion of applications in vaccines, protein replacement, and gene editing.
Main Results:
- Identified multiple biological barriers impacting mRNA therapeutic delivery.
- Highlighted the role of nanocarriers in enhancing targeted and responsive mRNA release.
- Showcased diverse biomedical applications of precision mRNA delivery strategies.
Conclusions:
- Nanocarrier-mediated strategies are crucial for overcoming mRNA delivery challenges.
- Optimizing administration routes, targeting, and release mechanisms are key for precision therapies.
- Further development is needed to address clinical needs and accelerate mRNA therapeutic applications.
Related Concept Videos
01:25Nucleic Acid Structure
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA has a double-helix structure. The...
DNA Structure
DNA has a double-helix structure. The...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:22Regulated mRNA Transport
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...